Details for New Drug Application (NDA): 087742
✉ Email this page to a colleague
NDA 087742 describes OXYCODONE AND ASPIRIN (HALF-STRENGTH), which is a drug marketed by Roxane and is included in one NDA. Additional details are available on the OXYCODONE AND ASPIRIN (HALF-STRENGTH) profile page.
The generic ingredient in OXYCODONE AND ASPIRIN (HALF-STRENGTH) is aspirin; oxycodone hydrochloride; oxycodone terephthalate. There are twenty-two drug master file entries for this compound. Additional details are available on the aspirin; oxycodone hydrochloride; oxycodone terephthalate profile page.
The generic ingredient in OXYCODONE AND ASPIRIN (HALF-STRENGTH) is aspirin; oxycodone hydrochloride; oxycodone terephthalate. There are twenty-two drug master file entries for this compound. Additional details are available on the aspirin; oxycodone hydrochloride; oxycodone terephthalate profile page.
Summary for 087742
| Tradename: | OXYCODONE AND ASPIRIN (HALF-STRENGTH) |
| Applicant: | Roxane |
| Ingredient: | aspirin; oxycodone hydrochloride; oxycodone terephthalate |
| Patents: | 0 |
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 325MG;2.25MG;0.19MG | ||||
| Approval Date: | Jun 4, 1982 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
